Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes, International Immunology, vol.8, issue.5, pp.765-772, 1996. ,
DOI : 10.1093/intimm/8.5.765
Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors, Cancer Discovery, vol.3, issue.12, pp.1355-63, 2013. ,
DOI : 10.1158/2159-8290.CD-13-0310
Thyroid involvement in patients with overt HCV-related mixed cryoglobulinaemia, QJM, vol.97, issue.8, pp.499-506, 2004. ,
DOI : 10.1093/qjmed/hch088
URL : https://academic.oup.com/qjmed/article-pdf/97/8/499/4508204/hch088.pdf
Autoimmune thyroid disorders, Autoimmunity Reviews, vol.14, issue.2, pp.174-180, 2015. ,
DOI : 10.1016/j.autrev.2014.10.016
Thyroid Autoimmune Disease, The American Journal of Pathology, vol.159, issue.3, pp.861-73, 2001. ,
DOI : 10.1016/S0002-9440(10)61762-2
Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti???Cytotoxic T-Lymphocyte Antigen-4, Journal of Clinical Oncology, vol.23, issue.25, pp.6043-53, 2005. ,
DOI : 10.1200/JCO.2005.06.205
Restoring function in exhausted CD8 T cells during chronic viral infection, Nature, vol.111, issue.7077, pp.682-687, 2006. ,
DOI : 10.1016/S0092-8674(02)01139-X
High levels of human anti-human antibodies to adalimumab in a patient not responding to adalimumab treatment, Annals of the Rheumatic Diseases, vol.65, issue.9, pp.1249-1250, 2006. ,
DOI : 10.1136/ard.2005.049858
Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment, Annals of the Rheumatic Diseases, vol.76, issue.10, pp.1747-50, 2017. ,
DOI : 10.1136/annrheumdis-2017-211216
The Sodium-Iodide Symporter NIS and Pendrin in Iodide Homeostasis of the Thyroid, Endocrinology, vol.150, issue.3, pp.1084-90, 2009. ,
DOI : 10.1210/en.2008-1437
Molecular and Biochemical Aspects of the PD-1 Checkpoint Pathway, New England Journal of Medicine, vol.375, issue.18, pp.1767-78, 2016. ,
DOI : 10.1056/NEJMra1514296
Phase I Study of Single-Agent Anti???Programmed Death-1 (MDX-1106) in Refractory Solid Tumors: Safety, Clinical Activity, Pharmacodynamics, and Immunologic Correlates, Journal of Clinical Oncology, vol.28, issue.19, pp.3167-75, 2010. ,
DOI : 10.1200/JCO.2009.26.7609
Association of the thyroid stimulating hormone receptor gene (TSHR) with Graves' disease, Human Molecular Genetics, vol.18, issue.9, pp.1704-1717, 2009. ,
DOI : 10.1093/hmg/ddp087
Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text, 2012. ,
Twin studies as a model for exploring the aetiology of autoimmune thyroid disease, Clinical Endocrinology, vol.18, issue.4, pp.457-464, 2012. ,
DOI : 10.1038/ejhg.2009.156
A systematic review of immune-related adverse event reporting in clinical trials of immune checkpoint inhibitors, Annals of Oncology, vol.26, issue.9, pp.1824-1853, 2015. ,
Advances in immunoassay technology, 2012. ,
DOI : 10.5772/1967
Polycopié d'enseignement d'Anatomie pathologique Disponible sur, 2011. ,
Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials, Oncotarget, vol.8, issue.5, pp.8910-8930, 2017. ,
DOI : 10.18632/oncotarget.13315
Exploration de l'auto-immunité thyroïdienne : apport du laboratoire, Annales de Biologie Clinique, vol.59, issue.6, pp.717-723, 2001. ,
Thyroxine Promotes Association of Mitogen-activated Protein Kinase and Nuclear Thyroid Hormone Receptor (TR) and Causes Serine Phosphorylation of TR, Journal of Biological Chemistry, vol.273, issue.48, pp.38032-38071, 2000. ,
DOI : 10.1006/bbrc.1996.0777
Comprehensive Meta-analysis of Key Immune-Related Adverse Events from CTLA-4 and PD-1/PD-L1 Inhibitors in Cancer Patients, Cancer Immunology Research, vol.5, issue.4, pp.312-318, 2017. ,
DOI : 10.1158/2326-6066.CIR-16-0237
Erratum: Tumor-associated B7-H1 promotes T-cell apoptosis: A potential mechanism of immune evasion, Nature Medicine, vol.49, issue.8, pp.793-800, 2002. ,
DOI : 10.1002/1531-8249(20010201)49:2<146::AID-ANA34>3.0.CO;2-E
Factitious Graves' Disease Due to Biotin Immunoassay Interference???A Case and Review of the Literature, The Journal of Clinical Endocrinology & Metabolism, vol.101, issue.9, pp.3251-55, 2016. ,
DOI : 10.1210/jc.2016-1971
Fluctuations in routine blood count might signal severe immunerelated adverse events in melanoma patients treated with nivolumab, Journal of Dermatological Science, 2017. ,
Autoimmune diabetes induced by PD-1 inhibitor-retrospective analysis and pathogenesis: a case report and literature review. Cancer immunology, immunotherapy: CII, 2017. ,
DOI : 10.1007/s00262-017-2033-8
Nivolumab-induced autoimmune diabetes mellitus presenting as diabetic ketoacidosis in a patient with metastatic lung cancer, Journal for ImmunoTherapy of Cancer, vol.53, issue.2, p.40, 2017. ,
DOI : 10.2337/diabetes.53.2.384
The HLA region and autoimmune disease: associations and mechanisms of action, Curr Genomics, vol.8, pp.453-65, 2007. ,
Human T cell activation. II. A new activation pathway used by a major T cell population via a disulfide-bonded dimer of a 44 kilodalton polypeptide (9.3 antigen), Journal of Experimental Medicine, vol.161, issue.6, pp.1513-1524, 1985. ,
DOI : 10.1084/jem.161.6.1513
Zur Kenntnis der Lymphomatösen Veränderung der Schilddrüse (Struma lymphomatosa) Archiv für Klinische Chirurgie, pp.219-248, 1912. ,
Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): Evaluation and management of adverse drug reactions, Cancer Treatment Reviews, vol.57, pp.36-49, 2017. ,
DOI : 10.1016/j.ctrv.2017.05.003
Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death, The EMBO journal, vol.11, issue.11, pp.3887-95, 1992. ,
A case of fulminant type 1 diabetes mellitus, with a precipitous decrease in pancreatic volume, induced by nivolumab for malignant melanoma: analysis of HLA and CTLA-4 polymorphisms, European journal of dermatology, vol.27, issue.2, pp.184-185, 2017. ,
Antigen Monoclonal Antibody in the Treatment of Patients with Metastatic Medullary Thyroid Carcinoma, Cancer, vol.85, pp.1828-1842, 1999. ,
A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities, Nature Genetics, vol.274, issue.Suppl 1, pp.478-85, 2005. ,
DOI : 10.1074/jbc.274.25.17837
Isolated ACTH deficiency probably induced by autoimmune-related mechanism evoked with nivolumab, Japanese Journal of Clinical Oncology, vol.47, issue.5, pp.463-466, 2017. ,
DOI : 10.1093/jjco/hyx018
Interference with clinical laboratory analyses, Clinical Chemistry, vol.40, issue.11, pp.1996-2005, 1994. ,
A PD-1 polymorphism is associated with disease progression in multiple sclerosis, Annals of Neurology, vol.25, issue.1, pp.50-57, 2005. ,
DOI : 10.4049/jimmunol.170.7.3637
CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells, Journal of Experimental Medicine, vol.183, issue.6, pp.2533-2573, 1996. ,
DOI : 10.1084/jem.183.6.2533
Current Diagnosis and Management of Immune Related Adverse Events (irAEs) Induced by Immune Checkpoint Inhibitor Therapy, Frontiers in Pharmacology, vol.8, 2017. ,
Association of the programmed cell death 1 (PDCD1) gene polymorphism with ankylosing spondylitis in the Korean population, 2006. ,
Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes, Nature Genetics, vol.1, issue.9, pp.1074-82, 2007. ,
DOI : 10.1086/338007
Mode d'action des hormones thyroïdiennes. Les Récepteurs nucléaires, Disponible sur ,
Pembrolizumab versus Chemotherapy for PD-L1???Positive Non???Small-Cell Lung Cancer, New England Journal of Medicine, vol.375, issue.19, pp.1823-1856, 2016. ,
DOI : 10.1056/NEJMoa1606774
Aggravation of diabetes, and incompletely deficient insulin secretion in a case with type 1 diabetes-resistant human leukocyte antigen DRB1*15:02 treated with nivolumab, Journal of Diabetes Investigation, vol.2, 2017. ,
DOI : 10.1007/s12185-016-2101-4
The incidence and prevalence of thyroid autoimmunity, Endocrine, vol.75, issue.3, pp.252-65, 2012. ,
DOI : 10.1001/jama.1978.03280350066018
Thyroid Peroxidase as an Autoantigen, Thyroid, vol.17, issue.10, pp.939-948, 2007. ,
DOI : 10.1089/thy.2007.0169
Heterophilic antibody interference affecting multiple hormone assays: Is it due to rheumatoid factor?, Scandinavian Journal of Clinical and Laboratory Investigation, vol.48, issue.3, pp.76-240, 2016. ,
DOI : 10.1210/jc.2014-4023
Thyroid abnormalities following the use of cytotoxic T-lymphocyte antigen-4 and programmed death receptor protein-1 inhibitors in the treatment of melanoma, Clinical Endocrinology, vol.21, issue.4, pp.614-620, 2017. ,
DOI : 10.1158/1078-0432.CCR-14-2353
Tag SNP screening of the PDCD1 gene for association with Graves? disease, Clinical Endocrinology, vol.13, issue.1, pp.125-128, 2007. ,
DOI : 10.1111/j.1365-2265.2006.02608.x
Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes, Tissue Antigens, vol.167, issue.6, pp.492-497, 2003. ,
DOI : 10.1084/jem.192.7.1027
Development of Lupus-like Autoimmune Diseases by Disruption of the PD-1 Gene Encoding an ITIM Motif-Carrying Immunoreceptor, Immunity, vol.11, issue.2, pp.141-151, 1999. ,
DOI : 10.1016/S1074-7613(00)80089-8
Interferon induced Autoimmune Thyroid Disease (AITD): a model for human autoimmunity, Autoimmunity Reviews, vol.3, issue.5, pp.388-393, 2004. ,
DOI : 10.1016/j.autrev.2004.03.003
The blockade of immune checkpoints in cancer immunotherapy, Nature Reviews Cancer, vol.12, issue.4, pp.252-264, 2012. ,
DOI : 10.1038/nrc3237
PD-1 gene polymorphic variation is linked with first symptom of disease and severity of relapsing-remitting form of MS, Journal of Neuroimmunology, vol.305, pp.115-127, 2017. ,
DOI : 10.1016/j.jneuroim.2017.02.006
Is Birthweight Associated with Thyroid Autoimmunity? A Study in Twins, Thyroid, vol.12, issue.5, pp.377-380, 2004. ,
DOI : 10.1089/105072502760043440
Thyronamines???Past, Present, and Future, Endocrine Reviews, vol.32, issue.1, pp.64-80, 2011. ,
DOI : 10.1210/er.2009-0040
URL : https://academic.oup.com/edrv/article-pdf/32/1/64/10335167/edrv0064.pdf
Les prot??ines d??couplantes mitochondriales., m??decine/sciences, vol.14, issue.8-9, pp.889-97, 1998. ,
DOI : 10.4267/10608/1160
Mutation, New England Journal of Medicine, vol.372, issue.4, pp.320-330, 2015. ,
DOI : 10.1056/NEJMoa1412082
URL : https://hal.archives-ouvertes.fr/hal-00872683
Le cheminement de l'iode dans la glande thyroïde, Annales d'Endocrinologie, vol.64, issue.1, pp.4-7, 2003. ,
In vitro complex formation and biodistribution of mouse antitumor monoclonal antibody in cancer patients, Journal of Nuclear Medicine, issue.8, pp.30-1311, 1989. ,
Falsely Elevated Thyroid-Stimulating Hormone (TSH) Level Due to Macro-TSH, Endocrine Journal, vol.56, issue.3, pp.435-440, 2009. ,
DOI : 10.1507/endocrj.K08E-361
Dosages de thyroxine (T4) et tri-iodothyronine (T3) : techniques et place dans le bilan thyroïdien fonctionnel, Annales Biologie Clinique, vol.61, pp.411-420, 2003. ,
Interférences dans les immunodosages : mécanismes et conséquences en endocrinologie. Annales d'Endocrinologie, pp.415-425, 2008. ,
DOI : 10.1016/j.ando.2008.04.002
Replication of an Association Between the Lymphoid Tyrosine Phosphatase Locus (LYP/PTPN22) With Type 1 Diabetes, and Evidence for Its Role as a General Autoimmunity Locus, Diabetes, vol.53, issue.11, pp.3020-3023, 2004. ,
DOI : 10.2337/diabetes.53.11.3020
Vésicules thyroïdiennes. Atlas d'anatomie humaine et animale, Disponible sur ,
CD28 activation pathway regulates the production of multiple T-cell-derived lymphokines/cytokines., Proceedings of the National Academy of Sciences, vol.86, issue.4, pp.1333-1370, 1989. ,
DOI : 10.1073/pnas.86.4.1333
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target, Proceedings of the National Academy of Sciences, vol.86, issue.19, pp.17174-79, 2004. ,
DOI : 10.1093/jnci/86.19.1470
Searching for the Autoimmune Thyroid Disease Susceptibility Genes: From Gene Mapping to Gene Function, Endocrine Reviews, vol.24, issue.5, pp.694-717, 2003. ,
DOI : 10.1210/er.2002-0030
Hyponatraemia secondary to nivolumabinduced primary adrenal failure. Endocrinology, Diabetes & Metabolism Case Reports, 2016. ,
DOI : 10.1530/edm-16-0108
URL : http://doi.org/10.1530/edm-16-0108
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease, Nature, vol.52, issue.6939, pp.506-517, 2003. ,
DOI : 10.1093/nar/gnf052
Association of Serum Anti-GAD Antibody and HLA Haplotypes with Type 1 Diabetes Mellitus Triggered by??Nivolumab in Patients with Non???Small Cell Lung??Cancer, Journal of Thoracic Oncology, vol.12, issue.5, pp.41-43, 2017. ,
DOI : 10.1016/j.jtho.2016.12.015
Exophthalmus durch Hypertrophie des Zellgewebes in der Augenhöhle. Wochenschrift für die gesammte Heilkunde, pp.197-204228, 1840. ,
Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial. The Lancet, Oncology, vol.16, issue.4, pp.375-384, 2015. ,
Les maladies de la thyroïde, 2010. ,
Acute symptomatic hypocalcemia from immune checkpoint therapy-induced hypoparathyroidism, The American Journal of Emergency Medicine, vol.35, issue.7, p.1039, 2017. ,
Ipilimumab efficacy and safety in patients with advanced melanoma: a retrospective analysis of HLA subtype from four trials, Cancer Immun J Acad Cancer Immunol, vol.10, 2010. ,
Assay of Plasma Insulin in Human Subjects by Immunological Methods, Nature, vol.18, issue.4699, pp.1648-1697, 1959. ,
DOI : 10.1038/1841648b0
Influence of Thyroid Hormone Autoantibodies on 7 Thyroid Hormone Assays, Clinical Chemistry, vol.54, issue.5, pp.927-928, 2008. ,
DOI : 10.1373/clinchem.2007.099770